[CIS PIDD] [cis-pidd] NFkappaB patietns

Sun Jun 5 17:41:31 EDT 2016

Sent from my iPad

On Jun 6, 2016, at 4:12 AM, CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>> wrote:

Hi Bodo:  Could I use NK cell function as a screening test for suitable patients before ordering NFKB1/NFKB2 sequence or would you suggest something else?  We don’t have the resources to order this sequence on all our patients.

I’d be happy to collaborate.

Prescott

T. Prescott Atkinson, MD PhD, Professor and Director
Division of Pediatric Allergy, Asthma & Immunology
University of Alabama at Birmingham
Tel 205-996-9582
Fax 205-975-7080

From: CIS-PIDD [mailto:cis-pidd at lists.clinimmsoc.org]
Sent: Saturday, June 04, 2016 3:58 PM
To: CIS-PIDD
Subject: [cis-pidd] NFkappaB patietns

Dear all,
In September 2015 we published that heterozygous mutation in NFkappaB1 can cause an antibody deficiency (CVID):
http://www.ncbi.nlm.nih.gov/pubmed/26279205<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=3W6ocp1Eb_d8o3vTshGKGQbFoteUgJqdmT1dpH0VDTc&e=>

Am J Hum Genet.<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=3W6ocp1Eb_d8o3vTshGKGQbFoteUgJqdmT1dpH0VDTc&e=> 2015 Sep 3;97(3):389-403. Epub 2015 Aug 13.
Fliegauf M<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DFliegauf-2520M-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=W3_OC0D_PuqL94WIL4LVr40vjsT_MOfZz4ScS_yDBGA&e=>1, Bryant VL<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DBryant-2520VL-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=4YM-tWVnhL9-7T2eFvG9h0-imgDQtP0_amyoB0rGsCQ&e=>2, Frede N<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DFrede-2520N-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=oj1HAhV8qBW4rWOg2_K9nx_73MYCi6fcSRa1uTUBJ_I&e=>1, Slade C<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DSlade-2520C-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=dMxClFqnH4-ghjkibmEPo-eDFH8xHXeVOi1nvJtbOIw&e=>3, Woon ST<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DWoon-2520ST-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=WbY4U5PGh6jZD2ZVZAdyfEWDgcgRbv74ep3f5ITTHM4&e=>4, Lehnert K<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DLehnert-2520K-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=jk2X5dHH7nPWmkz86yzVpZqVryIm6sWzrr5J6ZcWwvE&e=>5, Winzer S<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DWinzer-2520S-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=saJLuq-B54rquM5fu6Ed248jKYh8vLj-ZQHFNo7yK5o&e=>1, Bulashevska A<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DBulashevska-2520A-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=DKYUSmeOuxo5T3PvBz6f2VDUA9zyObmYZfpJRBv-PDE&e=>1, Scerri T<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DScerri-2520T-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=UUd9lfCNfvPikoYofr-8Zt1ZQr3ZrH5mdR0xIEPz_2g&e=>2, Leung E<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DLeung-2520E-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=XIFIgmde7xVMgdWNOSdRu8boCCaycxe2rktEK4w8GRA&e=>6, Jordan A<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DJordan-2520A-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=JfwvRS-0tx8coZp32gAfafZaJO9qpYInOJ9OEpA1dc8&e=>7, Keller B<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DKeller-2520B-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=rSseJWGxOsxqb1A5OHVLjdRLHV7FhaFz99cgMa55koI&e=>1, de Vries E<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3Dde-2520Vries-2520E-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=O4DAaEDBVMVTq-3LsPGkbVfF8BDRmyMiAWrTWiIaVZ0&e=>8, Cao H<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DCao-2520H-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=-AvhhPci4E6V0qT3cgwGL0S1MeozRiQfPXt6r7tWO7I&e=>9, Yang F<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DYang-2520F-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=KElTKAot6OrBuljXCV7thiJTzWiFmjefEONvo-sSXaE&e=>9, Schäffer AA<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DSch-25C3-25A4ffer-2520AA-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=mN_VKbVG3pJB-kd9MS0ORV-__TvquXDs6YejLWnFkD4&e=>10, Warnatz K<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DWarnatz-2520K-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=nGyg5FBgUtZuaTSxb_WzRCs__dfDp5WCaBFYfs7ui3c&e=>1, Browett P<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DBrowett-2520P-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=WclN865llzJc29xBEUlZvvxglquBuXHMmQOB6XULxfY&e=>6, Douglass J<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DDouglass-2520J-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=Fm2gHBLRMPfCIgYBvvtuNpXaBLi_P5ybQp-KfDksfoE&e=>11, Ameratunga RV<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DAmeratunga-2520RV-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=_R5viOOPgUm7TfLfu_d8Rn1o4V6wqKwb9e-8LF51kqM&e=>4, van der Meer JW<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3Dvan-2520der-2520Meer-2520JW-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=4cph7sqyZXbG9NB4g_PJwSX20GVGC5kBFjhBYxEqW9E&e=>12, Grimbacher B<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ncbi.nlm.nih.gov_pubmed_-3Fterm-3DGrimbacher-2520B-255BAuthor-255D-26cauthor-3Dtrue-26cauthor-5Fuid-3D26279205&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=HKC1SpBT3V8vUllEzLNZAQ5gpc-NgSf4FkHRWp9qdS8&e=>13
Haploinsufficiency of the NF-?B1 Subunit p50 in Common Variable Immunodeficiency.

Since, it became clear that mutations in NFkappaB 1 and 2 actually account for the majority of mutations in CVID:
Using next generation sequencing, we identified 33 mutations in NFKB1 and NFKB2 in a cohort of 320 CVID patients. Ten mutations in NFKB1 are predicted to lead to expression of truncated, non-functional proteins which undergo rapid decay, thus causing p50 haploinsufficiency. Four mutations are predicted to cause constitutive nuclear localization of aberrant p50 proteins and a shortcut or a delay in canonical NF-kappaB signaling. Fourteen missense variants were identified, with yet unknown effects. In NFKB2 we identified four frame-shift mutations leading to expression of unprocessable p100 precursor, and functional p52 haploinsufficiency. A novel frame-shift mutation suggests constitutive nuclear localization of a mutant p52. The phenotypical spectrum ranged from clinically inapparent IgG subclass deficiency to severe forms of CVID with progressing pulmonary disease, inflammatory bowel disease, and rheumatoid joint disease. In summary, mutations in NFKB1 or NFKB2 are highly prevalent and could account for approximately 10% of monogenetic defects in CVID.
(This is actually part of an abstract submitted to ESID 2016 by the following set of authors: Manfred Fliegauf, Katrin Hübscher, Jessica Rojas, Natalie Frede, Klaus Warnatz, Christian Klemann, Robin Kobbe, Vassilios Lougaris, Alessandro Plebani, Oliver Bartsch, Roya Sherkat, Mikko Seppänen, Lennart Hammarstöm, Vanessa Bryant, Jo Douglass, Anna Shcherbina, Siobhan Burns, Rohan Ameratunga, Jos van der Meer, and Bodo Grimbacher)

Therefore, we now think it is time to publish a large case series on patients with mutations in NFkappaB1 and 2:
To this end, I suggest to collect all the information of  patients with mutations in NFkappaB1;
and to share the work-load, Dr Karin Chen <karin.chen at hsc.utah.edu<mailto:karin.chen at hsc.utah.edu>> from the Department of Pediatrics at the University of Utah will collect the clinical data from all NFkappaB2 patients.

If you are interested in a collaboration, please reply to this Email:
bodo.grimbacher at uniklinik-freiburg.de<mailto:bodo.grimbacher at uniklinik-freiburg.de>

Best regards,
Yours, Bodo

****************************************
Univ.-Prof. Dr. med. B. Grimbacher

Scientific-Director
CCI-Center for Chronic Immunodeficiency
UNIVERSITÄTSKLINIKUM FREIBURG
Tel.: 0761 270-77731  Fax: -77744
Breisacherstraße 115, 79106 Freiburg
bodo.grimbacher at uniklinik-freiburg.de<mailto:bodo.grimbacher at uniklinik-freiburg.de>
www.uniklinik-freiburg.de/cci<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.uniklinik-2Dfreiburg.de_cci&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=umBSoNm0s3O4VsfWLvnvGpoMmgN_oGNiLAsqL9495t8&e=>

and

Consultant Immunologist
Institute of Immunity & Transplantation
Dept of Immunology
Royal Free Hospital
UNIVERSITY COLLEGE LONDON
Pond Street
London NW3 2QG
b.grimbacher at ucl.ac.uk<mailto:b.grimbacher at ucl.ac.uk>
www.centreforimmunodeficiency.com<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.centreforimmunodeficiency.com&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=dLHYgYCxuhX1pO0Ab7rN3TeQJYdQ-EQhg2kmR-9ftGc&e=>

---

You are currently subscribed to cis-pidd as: patkinson at peds.uab.edu<mailto:patkinson at peds.uab.edu>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396838.952f64cd9dda04997031bb8889426d86&n=T&l=cis-pidd&o=3677550<https://urldefense.proofpoint.com/v2/url?u=http-3A__cts.dundee.net_u-3Fid-3D96396838.952f64cd9dda04997031bb8889426d86-26n-3DT-26l-3Dcis-2Dpidd-26o-3D3677550&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=NB1Y-fzxAqRX5TEqEbwjse7o2IbmSjB9U2KKa_6RBEo&e=>

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3677550-96396838.952f64cd9dda04997031bb8889426d86 at lyris.dundee.net<mailto:leave-3677550-96396838.952f64cd9dda04997031bb8889426d86 at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: Kejian.zhang at cchmc.org<mailto:Kejian.zhang at cchmc.org>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396725.ba8df750ca45f500d1dbc3b686b6d9aa&n=T&l=cis-pidd&o=3678641<https://urldefense.proofpoint.com/v2/url?u=http-3A__cts.dundee.net_u-3Fid-3D96396725.ba8df750ca45f500d1dbc3b686b6d9aa-26n-3DT-26l-3Dcis-2Dpidd-26o-3D3678641&d=CwMFAw&c=P0c35rBvlN7D8BNx7kSJTg&r=S4GpNOPsYlGWp6onyzwL7w9X12bF7g_aYTLe7yi6xP8&m=AFH2UrICyUjkGiMcSBvv52eHVk2VA5I1J_mbKBDe4kQ&s=fhL5vURC3XjwhpgjsiCbuuWaelWKQMFYrr4zQZZcqzg&e=>

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3678641-96396725.ba8df750ca45f500d1dbc3b686b6d9aa at lyris.dundee.net<mailto:leave-3678641-96396725.ba8df750ca45f500d1dbc3b686b6d9aa at lyris.dundee.net>

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=3678750
or send a blank email to leave-3678750-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20160605/468eaa24/attachment-0001.html>